Biomarkers and Translational Research

Establish a traceable chain of scientific evidence and inquiry checklist, from candidate biomarker discovery, sample pre-processing, and analytical method selection to multi-platform validation.

Core Research Questions

  • Do candidate biomarkers have clear biological basis and measurable range?
  • Do sample collection, storage, and freeze-thaw cycles affect analytical results?
  • Can antibodies, primers, or standards meet specificity and dynamic range requirements?
  • Can tissue, cell, and body fluid results be validated by orthogonal and independent cohorts?

Common Samples & Models

  • Serum, plasma, urine, cerebrospinal fluid, and other bodily fluids
  • Fresh, frozen, or FFPE tissues
  • Cells, culture supernatants, nucleic acids, and protein extracts

Key Mechanisms & Observation Dimensions

  • Pre-analytical factors and analytical method compatibility
  • Protein, nucleic acid, cell, and tissue biomarker validation
  • Sensitivity, specificity, linearity, precision, and batch consistency

Recommended Experimental Workflows

Product Selection Entrance

Solution Design & Quality Requirements

It is recommended to pre-define research hypotheses, primary endpoints, negative and positive controls, biological replicates, exclusion criteria, and statistical methods. Different samples, species, platforms, and batches require independent compatibility confirmation, and original data, reagent lot numbers, and key operational records must be retained.

Please Provide When Submitting an Inquiry

  • Research objectives and mechanisms to be validated
  • Sample type, species, model, and estimated quantity
  • Planned experimental methods, instrument platforms, and throughput
  • Target analytes, required specifications, quality grade, and delivery region
  • Required instructions, SDS, CoA, or other quality documents

Submit product and technical inquiries for this research area

For Research Use Only: The content of this page is for research design, product selection, and technical communication, and does not constitute clinical diagnosis, treatment advice, or regulatory approval statements.